In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty. Today, we’re talking with several leaders at Prime about how each is focusing their work on the three pieces of our newly formed framework. We want to help make medications more affordable, deliver an easy, transparent experience and, most importantly, help people achieve better health. Pt. 1 – The specialty pharmacy shift – Reimagining for success In this segment, you’ll hear from Prime’s Senior Vice President, Specialty and Clinical Solutions, about why high-cost specialty drugs continue to dominate the pipeline. You’ll learn how Prime is making it easy for patients to access the specialty medicines they need, a simplified approach to a complex problem where we support patients in their journey. As a bonus, Steve also talks about how Prime’s new brand represents our ambition to become an icon for change and innovation in pharmacy solutions. Get insights into how Prime is reshaping pharmacy benefits management in a way that is patient centric, more affordable and more intuitive. Pt. 2 – Cell & gene therapy – The crossroads of sci-fi and reality The frontier of medicine is here, and we’re talking about cell and gene therapy. In this segment, VP of Clinical Strategy and Programs, Jim Rebello, discusses how medicines are causing a seismic shift and rewriting the way we treat conditions and the code to life itself. But these innovations bring a heavy price tag, so we dive into what Prime is doing to navigate this space. Pt. 3 – Health tech horizons – Diverse voices, unified innovation In this segment, Chief Information Officer, Dinesh Kandanchatha, dives into how technology plays a role in accelerating innovation to meet the moment for our customers. You’ll hear about his interview with Bill Nye the Science Guy from their closing keynote session from our Specialty Summit, where attendees heard about the developments in artificial intelligence and its potential impact on the health care industry and beyond.

In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty. In this segment, you’ll hear from Prime’s Senior Vice President, Specialty and Clinical Solutions, about why high-cost specialty drugs continue to dominate the pipeline. You’ll learn how Prime is making it easy for patients to access the specialty medicines they need, a simplified approach to a complex problem where we support patients in their journey. As a bonus, Steve also talks about how Prime’s new brand represents our ambition to become an icon for change and innovation in pharmacy solutions. Get insights into how Prime is reshaping pharmacy benefits management in a way that is patient centric, more affordable and more intuitive.

In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty. The frontier of medicine is here, and we’re talking about cell and gene therapy. In this segment, VP of Clinical Strategy and Programs, Jim Rebello, discusses how medicines are causing a seismic shift and rewriting the way we treat conditions and the code to life itself. But these innovations bring a heavy price tag, so we dive into what Prime is doing to navigate this space.

In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty. In this segment, Chief Information Officer, Dinesh Kandanchatha, dives into how technology plays a role in accelerating innovation to meet the moment for our customers. You’ll hear about his interview with Bill Nye the Science Guy from their closing keynote session from our Specialty Summit, where attendees heard about the developments in artificial intelligence and its potential impact on the health care industry and beyond.

GLP-1s and chronic weight management are two of the hottest topics in the medical industry. There isn’t nearly enough content devoted to weighing all the variables associated with them, which  our experts aim to address.  In this episode of the Pharmacy Friends podcast, “Weight management – a holistic journey,” our experts discuss Prime’s four primary tenants of practice for chronic weight management and how they play a role in ensuring any recommendations are rooted in the evidence focusing on improving patient adherence and persistence to treatment and driving value. Host, Maryam Tabatabai, vice president for clinical information at Prime Therapeutics, is joined by Pat Gleason PharmD, BCPS, FCCP, FAMCP, assistant vice president, health outcomes at Prime Therapeutics and Dariush Mozaffarian, M.D., Dr.P.H., Tufts University. Developing a holistic GLP-1 strategy Clinical Insights - Weight Management -- a holistic journey All Pharmacy Friends episodes

At Prime, we strive to provide the same care we would want for our loved ones. This purpose extends beyond our employees to encompass our members, clients and communities.  In today’s Power of People edition of Pharmacy Friends, we talk about how our employees help goes beyond our work in health care. On any given day, Prime’s people can be found serving others in the communities where we live and work.  Kerry Florian, vice president, total rewards, talks about Prime’s community giving program, PrimeCares, which brings employees together to donate, volunteer and participate in community events.  She also talks about working with our communities to address inequality and injustice in all its manifestations, particularly racism, poverty, health and hunger through the Prime Together Foundation.   And today’s guest Becky DeRosia, senior development officer, Hennepin Healthcare Foundation, talks about their great purpose of healing and enriching life in our community and how organizations like the Prime Together Foundation are instrumental in their work.  ⁠Corporate social responsibility⁠ ⁠PrimeCares⁠ ⁠PrimeTogether Foundation⁠ ⁠WATCH: PrimeTogether Foundation + Hennepin Healthcare Foundation ⁠+ ⁠Faith support for families experiencing trauma offers comfort, builds trust in health care system

A Power of People edition. In today’s episode, Many Voices, One Purpose, you'll find out the true power of people and how Prime is an organization that continues to commit to diversity, equity and inclusion efforts. Our host Laura Spitzack, talks with Zabrina Watkins, Melissa Strong and Pat Milligan, about how we unite through common values to find our path, keep growing and fundamentally strengthen our culture and the value we bring to all our partners and the communities we are privileged to serve. You'll discover the true meaning behind "radical welcomeness," as they explore topics related to our DEI Council, Corporate Social responsibility and what’s on the horizon. You will also hear how we unite as one culture, with one purpose, and foster partnerships to collectively craft a better, more equitable and inclusive future for our employees and the people we serve. 2023 Corporate Social Responsibility Report Our culture Power of People video series https://www.primetherapeutics.com/

Jazz-laden melodies are typically the sonic output of “The Big Easy” but this week, it’s a special episode as we take you to the Academy of Managed Care Pharmacy (AMCP) Annual Meeting, which was in New Orleans. Leading researchers from Prime Therapeutics are at the show, and we talk with these health care experts from our Clinical and Health Outcomes teams who are using integrated medical and pharmacy claims data to evaluate real-world drug utilization, managed care pharmacy programs, and associated costs of care for a range of conditions, including weight loss, cardiovascular disease, cancer, and multiple sclerosis.  And, in the spirit of our host city, we have a little fun with our guests and see how much they know about “The Big Easy.”  We even had a drop in visit from Susan Cantrell, AMCP CEO, who talked with us about how AMCP is on the forefront of pharmacy trends, but also how the organization seeks to improve access to care and reduce costs, particularly as health care trends show that the pharmacy benefit is becoming more expensive.  Dig into the research All newsroom content https://www.primetherapeutics.com/ Guests:   Landon Marshall, principal, health outcomes research  Ben Urick, senior principal, health outcomes research  Yuqian Liu, senior director, clinical account services  Kyle Thompson, principal, data scientist  Nick Friedlander, clinical program pharmacist  Pat Gleason, assistant vice president, health outcomes  David Eckwright, senior director, clinical project and program management  Kristen Reimers, senior vice president of specialty clinical solutions

This year marks the second AMCP Annual meeting where Prime has showed up as one organization. But what does it mean for our business to show up at a crucial trade event like this? We are joined by two of our leaders responsible for putting our best foot forward at AMCP Annual, Pat Gleason, Assistant Vice President of Health Outcomes, and David Eckwright, Senior Director of Clinical Project and Program Management, to tell us more.

We are fortunate to have Susan Cantrell, AMCP CEO, join us for a conversation on what this show means and how it continues to have an impact on the health care industry.

Four of the Prime studies presented at AMCP relate to glucagon-like peptide-1 agonist – or GLP-1 – drugs. Earlier analysis of real-world data showed low adherence and increased cost of care for individuals in the first year of GLP-1 therapy. Prime has been a leader in GLP-1 insights, and three studies at AMCP take a fresh look at the GLP-1 data as it relates to weight loss. We have Ben Urick, Health Outcomes Reseach Senior Principal from Prime, here to walk us through the research.

Cancer care represents a rapidly rising and disproportionate share of overall health care spend. Medically integrated dispensing has been associated with better outcomes, lower waste and better patient care experiences for members receiving. Recognizing this value, payers have developed integrated dispensing networks to supplement traditional dispensing sites; however, little information is available comparing total cost of care. During this conversation with Landon Marshall, health outcomes research principal at Prime, we take a closer look at the AMCP study, Medically Integrated Dispensing of Oral Oncolytics: Real-World Cost of Care Comparison to Traditional Dispensing.

We’re about to hear about an award-winning research study. Recently, a number of generic multiple sclerosis medications supported by the American Academy of Neurology have become more widely available. Managed care pharmacists can aid individuals in transitioning to generic therapies, reducing total drug spend and member cost. But just how successful can this transition be? Prime researchers took a closer look, and Nick Friedlander, clinical program pharmacist with Prime, explains how transition may lead to remarkable savings and improved health outcomes.

A key aspect of what AMCP seeks to achieve is improved access to care, and our next study looks closely at the factors that may impact that access. Social determinants of health are the conditions in a person’s environment that affect health, function, and quality-of-life outcomes and risks. These factors contribute to as much as 80% of variation in health outcomes. In this segment, Kyle Thompson, data scientist principal with Prime, talks about how the development of a Medicare member-specific medication nonadherence risk score, related to social determinants of health, can improve how a member manages medication and adheres to their doctors prescription.

The mission of the Academy of Managed Care Pharmacy is to enhance the quality and affordability of health care. Prime is likewise focused on this same mission, which is even more crucial when you consider a key category driving health care spend today are specialty drugs, which are typically injections or infusions that are self-administered or administered by health care professionals.  We caught up with Kristen Reimers, clinical pharmacist and senior vice president, Specialty Clinical Solutions at Prime, to talk about some of the education sessions at AMCP that touch on this important business segment.

Nothing might matter more than getting new talented and bright pharmacists in our door to get hands-on experience of specialty and medical drug management from a managed care perspective. YuQian Liu, Senior Director of Clinical Account Services, talks about how our ASHP accredited residency program allows people interested in managed care pharmacy to build their careers. She talks about the importance of developing a firsthand understanding of medical and pharmacy benefit integration and strategy. And touches on the skills and mindset needed that helps kick-start careers as a managed care pharmacist.

In this special edition of Pharmacy Friends, Mostafa Kamal, Prime Therapeutics, President and CEO, joined Capital Rx’s Chief Executive Officer AJ Loiacono and SVP of Marketing & Communications Michael Passanante on the Astonishing Healthcare Podcast by Capital Rx. They share the story behind the strategic alliance between the organizations and their vision to reimagine pharmacy and provide better care to patients across the country leveraging next-generation technology: JUDI®.  Prime's Newsroom www.primetherapeutics.com All Pharmacy Friends episodes Capital Rx podcasts https://www.cap-rx.com/

Welcome to Pharmacy Friends – we bring industry experts to the same table to talk about what is happening in pharmacy today, what is coming, and most importantly, what it means to you. A hot topic in the health care industry is GLP1s and chronic weight management. In this last segment of our two-part episode, our experts discuss Prime’s analysis of real-world integrated pharmacy and medical claims data.  Hosting today’s episode “The Skinny on GLP1s,” is Maryam Tabatabai, vice president for clinical information. Joining her are two experts, David Lassen, a clinic pharmacist and Prime’s Chief Clinical Officer, who has strategic oversight of clinical services and support for customers. Pat Gleason, assistant vice president, leads Prime’s health outcomes team which performs deep dives into research data. These three experts discuss how their data shows low adherence and increased costs in the first year and how they hope to see additional data to refine our guidance on GLP1s and chronic weight management approaches. The Skinny on GLP-1s: Part 1 Real-world analysis of GLP-1a drugs for weight loss finds low adherence and increased cost in first year All Pharmacy Friends episodes https://www.primetherapeutics.com/

A hot topic in the health care industry is GLP1s and chronic weight management. In this first of a two-part episode, our experts discuss clinical evidence, drug information and appropriate patient selection for GLP1 use.   Hosting The Skinny on GLP1s,” is Maryam Tabatabai, vice president for clinical information, and is joined are two experts, Olivia Pane, a clinical pharmacist at Prime, who is also a certified diabetes care and education specialist by helping manage and treat diabetes, weight gain and other chronic conditions. Carole Kerzic, a drug information, and pipeline clinical pharmacist at Prime, who has extensive expertise following emerging therapeutics and investigational drugs from pipeline to post-FDA approval.    These experts discuss the role of lifestyle modification, upcoming drug pipeline decision and even tackle how celebrities and social media influencers have impacted the availability of these medicines.  Check out our other GLP1 content David Lassen Shares Insights on Prime/MRx Analysis on GLP-1 for Weight Loss in New Video Real-world analysis of GLP-1a drugs for weight loss finds low adherence and increased cost in first year ------------------------------------------------------------------ More about Prime News and information

In this episode, Navigating the RSV vaccine frontier, join Maryam Tabatabai, PharmD, a clinical information expert at Prime, as she talks about the new frontier of RSV monoclonal antibodies and vaccines with Scott Roberts, MD, an infectious disease expert from Yale University, who is navigating RSV season both professionally and personally. In this episode, these thought leaders discuss why RSV is a current hot topic in the health care industry and how it’s impacting both health care systems and patients who choose to get the vaccine. Listen to their discussion covering the CDC guidance on obtaining access, the impact and risk factors of the illness and vaccines in both pediatric and adult populations, along with some conversation about how RSV monoclonal antibodies and vaccines can be administered.  Content in this podcast is for informational or educational purposes only, and does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen. More about our company - https://www.primetherapeutics.com/ Newsroom - https://www.primetherapeutics.com/news/ Making pharmacy’s future brighter - https://www.primetherapeutics.com/about/reimagine-pharmacy/ Join Prime - https://www.primetherapeutics.com/careers/